117 established journals publish at least 20 % of their articles in Cellular and Molecular Neuroscience. 30 of them are fully open access. Where open-access journals charge a fee, the median is 3 150 USD. Highest recent citation rates: Pharmacological Reviews, Nature Neuroscience, Nature reviews. Neuroscience.
117 journals
Most relevant first: how much of a journal's work is in Cellular and Molecular Neuroscience, how many articles it publishes and how often they are cited. Click a column to sort.
| NeuronCell Press | 35 % | 370 | 14.31 | 689 | Subscription; open access option 10 400 USD |
| NeuropharmacologyElsevier BV | 50 % | 319 | 4.15 | 245 | Subscription; open access option 4 300 USD |
| Life SciencesElsevier BV | 36 % | 862 | 6.58 | 287 | Subscription; open access option 3 810 USD |
| European Journal of PharmacologyElsevier BV | 37 % | 767 | 4.73 | 276 | Subscription; open access option 3 230 USD |
| Nature NeuroscienceNature Portfolio | 30 % | 282 | 18.18 | 592 | Subscription; open access option 12 690 USD |
| Journal of NeuroscienceSociety for Neuroscience | 38 % | 754 | 4.29 | 651 | Subscription |
| Brain ResearchElsevier BV | 44 % | 399 | 3.53 | 399 | Subscription; open access option 3 360 USD |
| NeuropsychopharmacologySpringer Nature | 41 % | 283 | 4.87 | 306 | Subscription; open access option 5 290 USD |
| NeuroscienceElsevier BV | 42 % | 557 | 3.00 | 370 | Subscription; open access option 3 500 USD |
| PsychopharmacologySpringer Science+Business Media | 46 % | 255 | 3.24 | 287 | Subscription; open access option 4 390 USD |
| Pharmacology Biochemistry and BehaviorElsevier BV | 52 % | 131 | 2.96 | 211 | Subscription; open access option 3 650 USD |
| Neurochemistry InternationalElsevier BV | 40 % | 164 | 5.51 | 170 | Subscription; open access option 4 170 USD |
| Journal of NeurochemistryWiley | 38 % | 292 | 4.41 | 349 | Subscription; open access option 5 330 USD |
| Brain Research BulletinElsevier BV | 40 % | 302 | 3.75 | 203 | 3 280 USD |
| Trends in NeurosciencesElsevier BV | 37 % | 123 | 7.83 | 439 | Subscription; open access option 7 030 USD |
| Nature reviews. NeuroscienceNature Portfolio | 31 % | 118 | 15.46 | 571 | Subscription |
| Pharmacological ReviewsAmerican Society for Pharmacology and Experimental Therapeutics | 30 % | 60 | 27.77 | 352 | Subscription; open access option 4 500 USD |
| Pharmacological ResearchElsevier BV | 25 % | 485 | 11.12 | 220 | 4 130 USD |
| Trends in Pharmacological SciencesElsevier BV | 31 % | 132 | 10.81 | 319 | Subscription; open access option 7 030 USD |
| Frontiers in Cellular NeuroscienceFrontiers Media | 28 % | 496 | 5.37 | 175 | 3 801 USD |
| European Journal of NeuroscienceWiley | 35 % | 415 | 2.81 | 277 | Subscription; open access option 3 560 USD |
| Neurochemical ResearchSpringer Science+Business Media | 33 % | 288 | 3.95 | 163 | Subscription; open access option 4 590 USD |
| Neuroscience LettersElsevier BV | 39 % | 407 | 2.09 | 267 | Subscription; open access option 3 430 USD |
| Behavioural Brain ResearchElsevier BV | 33 % | 454 | 3.04 | 252 | Subscription; open access option 3 590 USD |
| Neuroscience & Biobehavioral ReviewsElsevier BV | 24 % | 440 | 8.04 | 375 | Subscription; open access option 4 860 USD |
| eNeuroSociety for Neuroscience | 32 % | 336 | 3.63 | 91 | 2 925 USD |
| Current Opinion in NeurobiologyElsevier BV | 34 % | 122 | 5.15 | 306 | Subscription; open access option 4 320 USD |
| Cellular and Molecular Life SciencesSpringer Nature | 24 % | 454 | 7.18 | 328 | 4 290 USD |
| PeptidesElsevier BV | 36 % | 119 | 4.22 | 174 | Subscription; open access option 3 710 USD |
| NeuropeptidesElsevier BV | 46 % | 57 | 3.26 | 104 | Subscription; open access option 3 530 USD |
| Molecular PsychiatrySpringer Nature | 22 % | 491 | 8.98 | 317 | Subscription; open access option 5 490 USD |
| Progress in NeurobiologyElsevier BV | 37 % | 98 | 4.46 | 325 | Subscription; open access option 5 190 USD |
| Frontiers in Molecular NeuroscienceFrontiers Media | 25 % | 431 | 5.07 | 142 | 3 801 USD |
| Experimental NeurologyElsevier BV | 28 % | 312 | 4.06 | 271 | Subscription; open access option 4 110 USD |
| Journal of Neuroscience MethodsElsevier BV | 34 % | 213 | 2.84 | 226 | Subscription; open access option 3 900 USD |
| Journal of Huntington s DiseaseIOS Press | 46 % | 45 | 3.09 | 49 | Subscription; open access option 4 150 USD |
| Journal of Neuroscience ResearchWiley | 36 % | 156 | 2.84 | 222 | Subscription; open access option 4 840 USD |
| Cellular and Molecular NeurobiologySpringer Science+Business Media | 30 % | 125 | 5.58 | 127 | Subscription; open access option 4 590 USD |
| Neurobiology of DiseaseElsevier BV | 25 % | 349 | 5.17 | 225 | 4 180 USD |
| Frontiers in Behavioral NeuroscienceFrontiers Media | 29 % | 312 | 3.57 | 138 | 3 801 USD |
| Annual Review of NeuroscienceAnnual Reviews | 34 % | 24 | 13.55 | 372 | Subscription |
| Molecular BrainBioMed Central | 32 % | 111 | 4.47 | 99 | 2 890 USD |
| Molecular and Cellular NeuroscienceElsevier BV | 37 % | 60 | 4.28 | 171 | Subscription; open access option 3 450 USD |
| Behavioural PharmacologyLippincott Williams & Wilkins | 55 % | 52 | 1.56 | 108 | Subscription |
| Journal of Neural TransmissionSpringer Science+Business Media | 32 % | 158 | 3.26 | 167 | Subscription; open access option 4 690 USD |
| Naunyn-Schmiedeberg s Archives of PharmacologySpringer Science+Business Media | 25 % | 570 | 3.59 | 166 | Subscription; open access option 4 790 USD |
| British Journal of PharmacologyWiley | 24 % | 356 | 5.13 | 318 | Subscription; open access option 4 780 USD |
| Pharmacology & TherapeuticsElsevier BV | 21 % | 148 | 13.04 | 295 | Subscription; open access option 5 660 USD |
| The Journal of Comparative NeurologyWiley | 38 % | 154 | 2.05 | 431 | Subscription; open access option 5 450 USD |
| Neural Regeneration ResearchMedknow | 21 % | 533 | 5.55 | 100 | 1 500 USD |
| Neuroscience ResearchElsevier BV | 38 % | 112 | 2.33 | 145 | 2 770 USD |
| Frontiers in Neural CircuitsFrontiers Media | 34 % | 105 | 3.05 | 115 | 3 801 USD |
| Progress in Neuro-Psychopharmacology and Biological PsychiatryElsevier BV | 28 % | 231 | 3.65 | 188 | Subscription; open access option 4 380 USD |
| Addiction NeuroscienceElsevier BV | 44 % | 45 | 2.62 | 19 | 2 660 USD |
| Pharmacological ReportsElsevier BV | 29 % | 123 | 4.23 | 98 | Subscription; open access option 3 290 USD |
| Addiction BiologyWiley | 35 % | 123 | 2.52 | 116 | 3 150 USD |
| ACS Chemical NeuroscienceAmerican Chemical Society | 22 % | 419 | 4.32 | 124 | Subscription; open access option 4 500 USD |
| Journal of PsychopharmacologySAGE Publishing | 27 % | 137 | 4.43 | 168 | Subscription; open access option 4 400 USD |
| Annals of the New York Academy of SciencesWiley | 25 % | 221 | 3.95 | 398 | Subscription; open access option 5 080 USD |
| SynapseWiley | 55 % | 37 | 1.40 | 155 | Subscription; open access option 3 570 USD |
| Fluids and Barriers of the CNSBioMed Central | 24 % | 102 | 6.85 | 86 | 3 390 USD |
| IBRO Neuroscience ReportsElsevier BV | 23 % | 558 | 3.06 | 28 | 2 400 USD |
| The CerebellumSpringer Science+Business Media | 30 % | 146 | 2.65 | 107 | Subscription; open access option 4 790 USD |
| NeuroreportLippincott Williams & Wilkins | 31 % | 134 | 2.44 | 242 | Subscription |
| Neuroscience BulletinSpringer Science+Business Media | 24 % | 185 | 3.73 | 88 | Subscription; open access option 4 490 USD |
| Insect Biochemistry and Molecular BiologyElsevier BV | 28 % | 113 | 3.00 | 162 | Subscription; open access option 4 210 USD |
| Genes Brain & BehaviorWiley | 37 % | 54 | 2.11 | 122 | Subscription; open access option 3 540 USD |
| Frontiers in Synaptic NeuroscienceFrontiers Media | 40 % | 44 | 1.85 | 68 | 3 801 USD |
| Journal of Insect PhysiologyElsevier BV | 32 % | 92 | 2.23 | 164 | Subscription; open access option 3 430 USD |
| Drug Development ResearchWiley | 23 % | 149 | 3.87 | 97 | Subscription; open access option 3 980 USD |
| Journal of Molecular NeuroscienceSpringer Science+Business Media | 26 % | 139 | 2.70 | 118 | Subscription; open access option 4 990 USD |
| Reviews in the NeurosciencesDe Gruyter | 27 % | 55 | 4.52 | 108 | Subscription; open access option 2 712 USD |
| Cell and Tissue ResearchSpringer Science+Business Media | 25 % | 139 | 3.18 | 228 | Subscription; open access option 5 290 USD |
| The NeuroscientistSAGE Publishing | 31 % | 56 | 2.86 | 175 | Subscription; open access option 4 400 USD |
| Journal of NeurophysiologyAmerican Physiological Society | 21 % | 297 | 2.83 | 427 | Subscription |
| Journal of Pharmacology and Experimental TherapeuticsAmerican Society for Pharmacology and Experimental Therapeutics | 30 % | 530 | 1.00 | 325 | Subscription; open access option 3 750 USD |
| Frontiers in NeuroanatomyFrontiers Media | 24 % | 96 | 3.43 | 116 | 3 801 USD |
| Neurobiology of StressElsevier BV | 22 % | 89 | 4.35 | 74 | 4 050 USD |
| Neurotoxicity ResearchSpringer Science+Business Media | 24 % | 92 | 3.26 | 103 | Subscription; open access option 4 590 USD |
| Neurology GeneticsWolters Kluwer | 25 % | 92 | 2.83 | 53 | 3 300 USD |
| Learning & MemoryCold Spring Harbor Laboratory Press | 29 % | 43 | 2.99 | 175 | Open access, fee unknown |
| Developmental NeurobiologyWiley | 33 % | 49 | 2.00 | 100 | Subscription; open access option 4 550 USD |
| Current NeuropharmacologyBentham Science Publishers | 21 % | 177 | 2.80 | 139 | Subscription |
| Molecular PharmacologyAmerican Society for Pharmacology and Experimental Therapeutics | 22 % | 94 | 3.55 | 274 | Subscription; open access option 3 600 USD |
| Journal of Comparative Physiology ASpringer Science+Business Media | 28 % | 67 | 2.19 | 184 | Subscription; open access option 3 990 USD |
| HippocampusWiley | 22 % | 102 | 3.01 | 215 | Subscription; open access option 4 780 USD |
| BMC NeuroscienceBioMed Central | 22 % | 76 | 4.06 | 135 | 2 990 USD |
| Archives of Insect Biochemistry and PhysiologyWiley | 27 % | 112 | 1.75 | 94 | Subscription; open access option 3 920 USD |
| Behavioral NeuroscienceAmerican Psychological Association | 30 % | 59 | 1.80 | 217 | Subscription |
| European NeuropsychopharmacologyElsevier BV | 24 % | 846 | 0.99 | 157 | Subscription; open access option 3 000 USD |
| Neurobiology of Learning and MemoryElsevier BV | 26 % | 91 | 1.91 | 155 | Subscription; open access option 4 000 USD |
| The Annual Review of Pharmacology and ToxicologyAnnual Reviews | 20 % | 31 | 9.37 | 295 | Subscription |
| Journal of Pharmacological SciencesElsevier BV | 21 % | 99 | 3.07 | 106 | 2 070 USD |
| Journal of the Peripheral Nervous SystemWiley | 26 % | 78 | 1.93 | 89 | Subscription; open access option 4 550 USD |
| Journal of NeuroendocrinologyWiley | 20 % | 156 | 2.60 | 158 | Subscription; open access option 4 550 USD |
| Acta Neurobiologiae ExperimentalisNencki Institute of Experimental Biology | 36 % | 36 | 1.35 | 69 | Open access, fee unknown |
| NeuroMolecular MedicineSpringer Science+Business Media | 21 % | 52 | 4.01 | 99 | Subscription; open access option 4 990 USD |
| Journal of NeurogeneticsTaylor & Francis | 51 % | 22 | 0.81 | 67 | Subscription |
| AlcoholElsevier BV | 27 % | 129 | 1.18 | 115 | Subscription; open access option 3 720 USD |
| International Journal of Developmental NeuroscienceWiley | 26 % | 91 | 1.44 | 119 | Subscription; open access option 3 400 USD |
| Neuroscience and Behavioral PhysiologySpringer Science+Business Media | 33 % | 174 | 0.68 | 45 | Subscription; open access option 3 890 USD |
| NeurogeneticsSpringer Science+Business Media | 26 % | 48 | 1.95 | 82 | Subscription; open access option 4 590 USD |
| CNS & Neurological Disorders - Drug TargetsBentham Science Publishers | 20 % | 107 | 2.25 | 114 | Subscription |
| Neural PlasticityHindawi Publishing Corporation | 23 % | 68 | 2.06 | 119 | 2 830 USD |
| ReceptorsMultidisciplinary Digital Publishing Institute | 26 % | 16 | 4.41 | 13 | 1 207 USD |
| Neuroscience InsightsSAGE Publishing | 21 % | 24 | 4.97 | 23 | 2 650 USD |
| The International Journal of NeuropsychopharmacologyUniversity of Oxford | 26 % | 324 | 0.66 | 156 | 2 693 USD |
| NeuropsychobiologyKarger Publishers | 21 % | 38 | 2.91 | 113 | Subscription |
| Developmental NeuroscienceKarger Publishers | 22 % | 54 | 1.89 | 117 | Subscription |
| Experimental NeurobiologyPublisher unknown | 22 % | 32 | 1.93 | 60 | Open access, fee unknown |
| Clinical NeuropharmacologyLippincott Williams & Wilkins | 21 % | 48 | 1.39 | 106 | Subscription |
| Visual NeuroscienceCambridge University Press | 22 % | 13 | 2.68 | 127 | Subscription; open access option 3 450 USD |
| Oxford Open NeuroscienceOxford University Press | 24 % | 9 | 2.78 | 13 | 2 400 USD |
| Folia Pharmacologica JaponicaJapanese Pharmacological Society | 26 % | 106 | 0.21 | 33 | Subscription |
| AbstractsPublisher unknown | 21 % | 954 | 0.07 | 22 | Subscription |
| e-NeuroforumPublisher unknown | 30 % | 15 | 0.00 | 22 | Subscription |
| Journal of Drug and Alcohol ResearchPublisher unknown | 27 % | 8 | 0.00 | 15 | Subscription |
Which of these fit your paper?
Paste your title and abstract and get these journals ranked for your work, with the closest published articles as evidence. Free, and your abstract is never stored.
Journals in CWTS Journal Indicators Core or the Directory of Open Access Journals that published at least 20 articles in the last five years, mostly in English. "In this field" is the share of a journal's articles that OpenAlex classifies in Cellular and Molecular Neuroscience. Citation rate is OpenAlex's two-year mean citedness, an open measure similar to the journal impact factor. Fees are taken from OpenAlex and DOAJ and can be out of date: always check the journal's own website before you submit.